Type 2 Diabetes and Pregnancy a Single-arm Interventional Study
NCT: NCT07602036 · NOT_YET_RECRUITING
Brief Summary
This single-arm interventional study evaluates the MiniMed 780G insulin pump and continuous glucose monitoring (CGM) system in pregnant women with type 2 diabetes enrolled at ≤ 16 weeks gestation. From recruitment to delivery, participants attend regular clinical visits for active insulin adjustments. The primary objective is to measure the percentage of time spent in the target pregnancy glucose range (63-140 mg/dL). Secondary outcomes track mean glucose, HbA1c, and overall maternal and neonatal health to ensure safety and efficacy.
Frequently Asked Questions
What is Type 2 Diabetes and Pregnancy a Single-arm Interventional Study?
Type 2 Diabetes and Pregnancy a Single-arm Interventional Study is a clinical trial registered under NCT07602036. Current status: NOT_YET_RECRUITING.
What is the status of NCT07602036?
The current status of NCT07602036 (Type 2 Diabetes and Pregnancy a Single-arm Interventional Study) is: NOT_YET_RECRUITING.
When did Type 2 Diabetes and Pregnancy a Single-arm Interventional Study start?
Type 2 Diabetes and Pregnancy a Single-arm Interventional Study started on 2026-05-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.